Intervention not reportedLDL‐Cholesterol rosuvastatin 2.5 mg/day · participantswith normal or abnormal lipid profiles1 finding from 1 reviewRosuvastatin for lowering lipids 2014 · Cochrane Headline outcomes onlyno estimate extracted11 studies · 450 participantsLow